Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$4.22 - $5.85 $93,325 - $129,372
-22,115 Reduced 5.25%
399,126 $1.8 Million
Q1 2022

Apr 19, 2022

SELL
$5.43 - $6.81 $866,823 - $1.09 Million
-159,636 Reduced 27.48%
421,241 $2.35 Million
Q4 2021

Jan 28, 2022

SELL
$5.21 - $6.82 $347,303 - $454,628
-66,661 Reduced 10.29%
580,877 $3.84 Million
Q3 2021

Nov 12, 2021

SELL
$5.25 - $5.87 $1.4 Million - $1.57 Million
-267,468 Reduced 29.23%
647,538 $3.43 Million
Q2 2021

Aug 05, 2021

BUY
$5.67 - $6.33 $275,788 - $307,891
48,640 Added 5.61%
915,006 $5.36 Million
Q1 2021

May 13, 2021

BUY
$6.02 - $8.06 $3.95 Million - $5.29 Million
656,533 Added 312.88%
866,366 $5.29 Million
Q4 2020

Feb 12, 2021

BUY
$6.3 - $8.46 $737,194 - $989,946
117,015 Added 126.07%
209,833 $1.35 Million
Q3 2020

Oct 30, 2020

BUY
$8.02 - $11.73 $744,400 - $1.09 Million
92,818 New
92,818 $793,000
Q1 2020

May 14, 2020

SELL
$4.56 - $7.13 $317,453 - $496,369
-69,617 Closed
0 $0
Q4 2019

Jan 31, 2020

SELL
$4.97 - $7.7 $39,541 - $61,261
-7,956 Reduced 10.26%
69,617 $478,000
Q3 2019

Nov 12, 2019

SELL
$5.11 - $5.99 $21,978 - $25,762
-4,301 Reduced 5.25%
77,573 $398,000
Q2 2019

Jul 30, 2019

SELL
$5.39 - $6.26 $22,390 - $26,004
-4,154 Reduced 4.83%
81,874 $452,000
Q1 2019

May 13, 2019

BUY
$5.12 - $6.18 $3,891 - $4,696
760 Added 0.89%
86,028 $484,000
Q4 2018

Feb 01, 2019

SELL
$4.68 - $6.25 $56,735 - $75,768
-12,123 Reduced 12.45%
85,268 $425,000
Q3 2018

Nov 07, 2018

SELL
$5.15 - $6.3 $114,051 - $139,519
-22,146 Reduced 18.53%
97,391 $606,000
Q2 2018

Aug 07, 2018

BUY
$4.4 - $5.3 $67,936 - $81,832
15,440 Added 14.83%
119,537 $616,000
Q1 2018

May 14, 2018

BUY
$4.6 - $5.75 $236,449 - $295,561
51,402 Added 97.55%
104,097 $477,000
Q4 2017

Feb 12, 2018

BUY
$4.35 - $5.15 $229,223 - $271,379
52,695
52,695 $251,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $271M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.